Delphistem vs Noom

Side-by-side comparison of AI visibility scores, market position, and capabilities

Noom leads in AI visibility (86 vs 36)
Delphistem logo

Delphistem

EmergingHealthcare

Induced Pluripotent Stem Cell Banking

Delphistem offers personalized iPSC (induced pluripotent stem cell) banking services, enabling individuals to store their cells at their youngest state for future regenerative medicine and disease detection applications.

AI VisibilityBeta
Overall Score
D36
Category Rank
#504 of 596
AI Consensus
85%
Trend
stable
Per Platform
ChatGPT
38
Perplexity
42
Gemini
42

About

Delphistem is a longevity-focused biotech company providing induced pluripotent stem cell (iPSC) storage services for individuals seeking to preserve their biological options for future personalized medicine. The company collects biological samples from clients, reprograms them into iPSCs — cells capable of differentiating into virtually any tissue type — and stores them cryogenically for long-term use in future medical treatments, disease risk detection, and cell replacement therapies.

Full profile
Noom logo

Noom

GrowthHealthcare

Weight Health Platform

Noom is a digital weight health program combining psychology-based behavioral coaching, food logging, and human coaching to help members build sustainable healthy habits.

AI VisibilityBeta
Overall Score
A86
Category Rank
#12 of 596
AI Consensus
67%
Trend
stable
Per Platform
ChatGPT
80
Perplexity
81
Gemini
92

About

Noom is a digital health company founded in 2008 that has grown into one of the most widely used weight management platforms, serving millions of members through its psychology-driven approach to behavior change. The platform combines daily lessons on cognitive behavioral techniques, food logging with a traffic-light color-coding system, personal coaching from trained health coaches, and group support to help members change their relationship with food and exercise. Noom raised over $540M and reached a $3.7B valuation, establishing it as a leading consumer digital health company. The company has expanded beyond weight loss into a broader weight health platform addressing both weight management and weight-related conditions including type 2 diabetes management with its Noom Med offering that includes GLP-1 medication prescribing. As GLP-1 medications like Ozempic and Wegovy have transformed the weight loss market, Noom has positioned its behavioral coaching as essential to sustainable results alongside medication. The platform serves both direct-to-consumer subscribers and employer health plans that offer Noom as a weight management benefit for their workforces.

Full profile

AI Visibility Head-to-Head

36
Overall Score
86
#504
Category Rank
#12
85
AI Consensus
67
stable
Trend
stable
38
ChatGPT
80
42
Perplexity
81
42
Gemini
92
37
Claude
90
38
Grok
83

Key Details

Category
Induced Pluripotent Stem Cell Banking
Weight Health Platform
Tier
Emerging
Growth
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only Noom
Weight Health Platform

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.